Blog

By Kevin Hrusovsky
As a company that believes we have the power to improve player safety, we also know that change cannot happen unless we have unified support from the entire community, including researchers, scientists, doctors, patients, patient advocates, investors, and institutions like the NFL.
By Dr. Mark Roskey and Dr. David Duffy
We were honored to be able to speak about the promise of immuno-oncology (IO) therapeutics at this year’s Molecular Med Tri-Con conference and the 12th Annual Biomarkers Congress.
BY KEVIN HRUSOVSKY, CEO AND EXECUTIVE CHAIRMAN, QUANTERIX
2016 has been a banner year for the healthcare and life sciences industries. This year we saw the launch of critical initiatives like the Vice President Biden’s Cancer Moonshot, aimed at improving our ability to prevent cancer and detect it an early stage.
BY KEVIN HRUSOVSKY, CEO AND EXECUTIVE CHAIRMAN, QUANTERIX
Thanks to recent moves by Congress last week, we’re one step closer to transforming the way in which we approach today’s sick care to true, precision healthcare.
BY KEVIN HRUSOVSKY, CEO AND EXECUTIVE CHAIRMAN, QUANTERIX
It is my pleasure to welcome you to the home of our new blog. We're particularly excited about launching this blog as it coincides with the re-launch of our Company’s website and new messaging focused on the science of precision health.